SCCO Southern delivers narrow Q4 2025 earnings beat shares edge down 1 percent on cautious investor sentiment SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today US Residential Real Estate PreMarketing Listing Strategy Industry Shift Analysis